DK1186298T3 - Indretninger og fremgangsmåder til indgivelse af cannabis til patienter - Google Patents

Indretninger og fremgangsmåder til indgivelse af cannabis til patienter

Info

Publication number
DK1186298T3
DK1186298T3 DK01307509T DK01307509T DK1186298T3 DK 1186298 T3 DK1186298 T3 DK 1186298T3 DK 01307509 T DK01307509 T DK 01307509T DK 01307509 T DK01307509 T DK 01307509T DK 1186298 T3 DK1186298 T3 DK 1186298T3
Authority
DK
Denmark
Prior art keywords
cannabis
cavity
chemical
backing layer
skin
Prior art date
Application number
DK01307509T
Other languages
English (en)
Inventor
Cal Cedric Herrmann
Su Ii Yum
Lawrence Lea Brooke
Original Assignee
Patch Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patch Tech Inc filed Critical Patch Tech Inc
Application granted granted Critical
Publication of DK1186298T3 publication Critical patent/DK1186298T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01307509T 2000-09-05 2001-09-04 Indretninger og fremgangsmåder til indgivelse af cannabis til patienter DK1186298T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/655,634 US6328992B1 (en) 1997-03-03 2000-09-05 Cannabinoid patch and method for cannabis transdermal delivery

Publications (1)

Publication Number Publication Date
DK1186298T3 true DK1186298T3 (da) 2006-05-08

Family

ID=24629717

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01307509T DK1186298T3 (da) 2000-09-05 2001-09-04 Indretninger og fremgangsmåder til indgivelse af cannabis til patienter

Country Status (10)

Country Link
US (1) US6328992B1 (da)
EP (1) EP1186298B1 (da)
AT (1) ATE313320T1 (da)
AU (1) AU785275B2 (da)
CA (1) CA2356020C (da)
CY (1) CY1104990T1 (da)
DE (1) DE60116011T2 (da)
DK (1) DK1186298T3 (da)
ES (1) ES2253331T3 (da)
PT (1) PT1186298E (da)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
US20020111377A1 (en) * 2000-12-22 2002-08-15 Albany College Of Pharmacy Transdermal delivery of cannabinoids
US10004684B2 (en) * 2001-02-14 2018-06-26 Gw Pharma Limited Pharmaceutical formulations
GB0202385D0 (en) * 2002-02-01 2002-03-20 Gw Pharma Ltd Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions
WO2003063847A1 (en) * 2002-02-01 2003-08-07 Gw Pharma Limited Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
WO2003066130A2 (en) * 2002-02-07 2003-08-14 Massachusetts Institute Of Technology Transdermal drug delivery systems
IL148244A0 (en) * 2002-02-19 2002-09-12 Yissum Res Dev Co Anti-nausea and anti-vomiting activity of cannabidiol compounds
AU2003240824B9 (en) * 2002-05-31 2008-09-25 University Of Mississippi Transmucosal delivery of cannabinoids
DE10226494A1 (de) * 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
WO2005000830A1 (en) * 2003-06-24 2005-01-06 Gw Pharma Limited Pharmaceutical compositions comprising cabbinochreme type compounds
CA2544900A1 (en) * 2003-11-05 2005-05-19 Unimed Pharmaceuticals, Inc. Delta-9- the treatment of multiple sclerosis
TWI369203B (en) 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
TWI366460B (en) 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
ZA200802767B (en) 2005-09-29 2009-09-30 Amr Technology Inc Process for production of delta-9-tetrahydrocannabinol
US20080008747A1 (en) * 2006-07-07 2008-01-10 Royds Robert B Transdermal patch
US20110150766A1 (en) * 2006-07-07 2011-06-23 Royds Robert B Transdermal patch with fatal overdose protection
US20100184848A1 (en) * 2006-07-14 2010-07-22 William Abraham Wine Transdermal formulations of synthetic cannabinoids and nano colloidal silica
DE102007006244B4 (de) * 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
JP5224163B2 (ja) * 2007-07-24 2013-07-03 コスメディ製薬株式会社 経皮吸収テープ製剤
CA2694325C (en) * 2007-07-30 2015-09-22 Alltranz Inc. Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
US20090259176A1 (en) * 2008-04-09 2009-10-15 Los Gatos Research, Inc. Transdermal patch system
WO2010150245A1 (en) * 2009-06-24 2010-12-29 Tikun Olam Ltd. Pharmaceutical and cosmeceutical compositions containing cannabis flower and seed extracts
US20110038915A1 (en) * 2009-08-14 2011-02-17 Eduardo Jose Gonzalez Chewing Gum Formula for Enhancing Psycho-Spirituality
US9155713B2 (en) * 2011-03-03 2015-10-13 Mark Stephen Saia Method and apparatus for alcohol administration and therapeutic treatments using same
US8758826B2 (en) * 2011-07-05 2014-06-24 Wet Inc. Cannabinoid receptor binding agents, compositions, and methods
US10319475B1 (en) 2014-06-13 2019-06-11 Enigami Systems, Inc. Method and apparatus for determining relationships between medications and symptoms
CA2956919C (en) 2014-07-21 2022-07-19 Glia, Llc Method for treating radiotherapy- and chemotherapy-associated cognitive or emotional impairment with cannabinoids
US11707556B2 (en) 2015-01-22 2023-07-25 Alps South, LLC Phase change material for thermal therapy and delivery of active ingredients
US9375417B2 (en) 2014-12-04 2016-06-28 Mary's Medicinals LLC Transdermal cannabinoid formulations
US10028904B2 (en) 2014-12-04 2018-07-24 Wisconsin Alumni Research Foundation Transdermal cannabinoid formulations
US20160220593A1 (en) * 2015-02-02 2016-08-04 Axim Biotechnologies, Inc. Cannabinoid and sugar alcohol complex, methods to make and use
US9962340B2 (en) * 2015-06-09 2018-05-08 Life Tech Global, Llc Device and method for the transdermal delivery of cannabidiol
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US10272125B2 (en) * 2015-09-14 2019-04-30 Life Tech Global, Llc Transdermal delivery of cannabidiol with other active moieties including cannabinoids
LT6486B (lt) * 2016-04-13 2018-01-10 UAB "SatiMed" Aliejinio gelio kompozicija su aktyviausiais junginiais iš c. sativa ir m. arvensis ir jos pateikimo sistema, skirta giliųjų audinių uždegimo ir skausmo mažinimui
WO2018034793A1 (en) 2016-07-21 2018-02-22 Alps South, LLC Phase change material for thermal therapy and delivery of active ingredients
KR20190088076A (ko) 2016-12-16 2019-07-25 소렌토 쎄라퓨틱스, 인코포레이티드 유체 전달 장치 및 조립 방법
KR20190088073A (ko) * 2016-12-16 2019-07-25 소렌토 쎄라퓨틱스, 인코포레이티드 유체 전달 장치용 부착 밴드 및 그 이용 방법
US10569010B2 (en) 2016-12-16 2020-02-25 Sorrento Therapeutics, Inc. Fluid delivery apparatus having a gas extraction device and method of use
JP7008709B2 (ja) 2016-12-16 2022-01-25 ソレント・セラピューティクス・インコーポレイテッド 制御アセンブリを有する流体送達装置及びその使用方法
KR102590629B1 (ko) 2016-12-16 2023-10-19 소렌토 쎄라퓨틱스, 인코포레이티드 유체 전달 장치용 어플리케이션 디바이스 및 그 이용 방법
KR20190088077A (ko) 2016-12-16 2019-07-25 소렌토 쎄라퓨틱스, 인코포레이티드 편두통 또는 군발두통을 치료하기에 적합한 투약 방법
WO2018125037A1 (en) * 2016-12-27 2018-07-05 John Garland Medical marijuana patch
GB2561262B (en) * 2017-07-13 2019-03-20 Dentmed Ltd A targeted drug delivery pad
WO2019016814A1 (en) 2017-07-20 2019-01-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. PHARMACEUTICAL FILM COMPOSITIONS FOR THE ADMINISTRATION OF LIPOPHILIC COMPOUNDS IN AND / OR THROUGH THE SKIN
CA3073799A1 (en) * 2017-08-24 2019-02-28 Zephyrious Health, Inc. Transdermal formulations suitable for administration of natural products comprising plant flour and an adhesive
SG11202003505RA (en) * 2017-10-17 2020-07-29 Remy Biosciences Inc Improved delivery systems for moieties including cbd enhanced combinations, formulations and chimeras
CA3108214A1 (en) 2018-07-18 2020-01-23 Glatt Gmbh Extended release formulations of cannabinoids
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
CA3113724A1 (en) * 2018-09-28 2020-04-02 Visceral Therapeutics Inc. Pharmaceutically active cannabis-based compositions and methods of use for treating gastrointestinal conditions
CA3077561A1 (en) * 2018-10-15 2020-04-15 Amnon VARDI Slow release cannabinoids and products thereof
WO2020236564A1 (en) * 2019-05-17 2020-11-26 Future Foam, Inc. Cannabidiol infused foam element or surface
US11090346B2 (en) 2019-05-28 2021-08-17 Inbold Inc. Cannabinoid composition and method of sublingual, buccal and oral mucosa delivery
US20230270803A1 (en) * 2019-08-21 2023-08-31 Pure GREEN PHARMACEUTICALS. INC. Medical apparatus with cannabis sativa l.
CA3156257A1 (en) * 2019-10-03 2021-04-08 Starton Therapeutics, Inc. TRANSDERMAL DELIVERY OF DRONABINOL
US12016829B2 (en) * 2019-10-11 2024-06-25 Pike Therapeutics Inc. Pharmaceutical composition and method for treating seizure disorders
US20210177740A1 (en) * 2019-12-11 2021-06-17 Joel Studin Transpore delivery of cannabinoid and uses thereof
WO2021138710A1 (en) * 2020-01-09 2021-07-15 Sg Ventures Pty Limited Substrate for use in a transdermal patch or dressing
US20210236687A1 (en) * 2020-01-31 2021-08-05 Pac-Dent, Inc. Cannabinoid-based oral hemostatic compositions
AU2021328741A1 (en) * 2020-08-17 2023-02-02 Pike Therapeutics, Inc. Pharmaceutical compositions and methods for treating Parkinson's disease
US20220087948A1 (en) * 2020-09-18 2022-03-24 Nanovibronix, Inc. Transdermal patch of a portable ultrasound-generating system for improved delivery of therapeutic agents and associated methods of treatment
WO2022118303A1 (en) * 2020-12-03 2022-06-09 Pike Therapeutics, Inc. Transdermal pharmaceutical formulations comprising cbd or thc for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US302116A (en) * 1884-07-15 Jean baptist alois db winteb
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US6113940A (en) * 1997-03-03 2000-09-05 Brooke; Lawrence L. Cannabinoid patch and method for cannabis transdermal delivery

Also Published As

Publication number Publication date
CY1104990T1 (el) 2009-11-04
US6328992B1 (en) 2001-12-11
DE60116011D1 (de) 2006-01-26
EP1186298A3 (en) 2003-01-02
EP1186298B1 (en) 2005-12-21
CA2356020C (en) 2006-12-19
AU785275B2 (en) 2006-12-14
ATE313320T1 (de) 2006-01-15
AU6554001A (en) 2002-03-07
ES2253331T3 (es) 2006-06-01
PT1186298E (pt) 2006-05-31
DE60116011T2 (de) 2006-08-24
EP1186298A2 (en) 2002-03-13
CA2356020A1 (en) 2002-03-05

Similar Documents

Publication Publication Date Title
DK1186298T3 (da) Indretninger og fremgangsmåder til indgivelse af cannabis til patienter
AU2961802A (en) Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system
DE50112720D1 (de) Transdermales therapeutisches system mit hochdispersem siliziumdioxid
DK0716620T3 (da) Reservoir,som kan imprægneres med en opløsning af aktivt stof, til en ionoforetisk anordning til transdermal indgivelse af medicin, og fremgangsmåde til fremstilling af et sådant reservoir
PT91327A (pt) Emplastro de varias camadas
YU165789A (en) Use of asymmetrical membranes in agents for active substances controlled releasing
DE69524436D1 (de) Verbesserte transdermale vorrichtung mit verringerter delaminierung
DK0674913T3 (da) Ikke-okklusivt klæbende plaster til påföring af medicament i huden
DK1524975T3 (da) Forbedret, transdermalt tilförselssystem til indgivelse af rotigotin
ATE526038T1 (de) Implantierbares medizinprodukt mit kontinuierlichem mittel-konzentrationsgefälle
JP2006525316A5 (da)
DK722888A (da) Plaster med aktivstof til kontrolleret administration af aktivstoffer til huden
WO2002078602A3 (en) Transdermal delivery of pergolide
DK1251853T3 (da) Transdermalt terapeutisk system til indgivelse af zaleplon
ATE416738T1 (de) Schiene mit feuchtigkeitsundurchlässiger lage
DE20221247U1 (de) Transdermal-Pflaster zum Verabreichen von Fentanyl